Real-time enrollment status for this episodic migraine clinical trial
Current Status
Active, Not Recruiting
Checked: March 2, 2026 at 12:08 PM UTC
| NCT Number | NCT03432286 |
| Recruiting Status | Active, Not Recruiting |
| Condition | Episodic Migraine |
| Phase | Clinical Trial |
| Target Enrollment | 325 participants |
| Active Locations | 38 sites in the US |
| Sponsor | Eli Lilly and Company |
| Last Updated on CT.gov | January 26, 2026 (Jan 26, 2026) |
As of March 2, 2026: Clinical trial NCT03432286 is currently active_not_recruiting participants. This clinical trial study for episodic migraine is not currently accepting new participants at 38 locations across the United States. The study is sponsored by Eli Lilly and Company. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT03432286 is currently active_not_recruiting. The study may resume recruiting in the future.
This trial is recruiting at 38 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT03432286 was last updated Jan 26, 2026 (January 26, 2026). HelloStudys verifies this status automatically.